NexgenRx

NexgenRx EBITDA per Employee

The EBITDA per Employee of NexgenRx (NXG.V) as of Nov 1, 2026 is 111,642.15 CAD. In the previous year, EBITDA per Employee was 123,190.30 CAD — a change of -9.37% (lower).

EBITDA per Employee

111,642.15CAD

YoY

-9.37%

Last updated:

EBITDA per Employee of NexgenRx is 2025 111,642.15 CAD. EBITDA per Employee of NexgenRx was 2024 123,190.30 CAD. It decreases by -9.37% lower compared to the previous year.

The NexgenRx EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
-12,020.95 CAD
Jan 1, 2019
46,315.80 CAD
Jan 1, 2020
154,759.80 CAD
Jan 1, 2021
176,713.15 CAD
Jan 1, 2022
84,657.90 CAD
Jan 1, 2023
58,186.20 CAD
Jan 1, 2024
123,190.30 CAD
Jan 1, 2025
111,642.15 CAD
The NexgenRx EBITDA per Employee history
YEAREBITDA per EmployeeYoY
111,642.15CAD-9.37%
123,190.30CAD+111.72%
58,186.20CAD-31.27%
84,657.90CAD-52.09%
176,713.15CAD+14.19%
154,759.80CAD+234.14%
46,315.80CAD-485.29%
-12,020.95CAD-39.88%
-19,995.45CAD-167.54%
29,605.55CAD-317.44%
-13,615.20CAD-7.12%
-14,659.15CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NexgenRx Stock analysis

What does NexgenRx do? NexgenRx Inc. is a Canadian company specializing in providing innovative and customer-oriented healthcare solutions. The company was founded in 1999 by Ron Loucks and is headquartered in Ontario. NexgenRx is a leading provider of cloud-based solutions, which help improve the efficiency and quality of healthcare insurance processes. The different business areas of NexgenRx can be divided into three main categories: 1) Health plan administration: NexgenRx serves a wide customer base consisting of companies of all sizes and industries. The company supports employers in offering their employees tailored and cost-effective healthcare benefits. The services include medical and dental care, drug therapies, hospital stays, vision and hearing tests, as well as occupational and disability insurance. 2) eClaims and digital healthcare services: NexgenRx has developed a range of innovative digital healthcare services aimed at making the lives of patients and policyholders easier and more convenient. These include mobile apps for accessing personal health information or an online platform for direct billing. NexgenRx's eClaims solution allows healthcare service providers to directly bill the company, enabling faster processing and less paperwork. 3) Healthcare consulting services: NexgenRx also offers healthcare consulting services. Customers can access the expertise of NexgenRx to assist with healthcare strategy development or the optimization of healthcare plans for their companies. NexgenRx offers a wide range of products and services for its customers, including the Smart Plan, a customizable healthcare program for companies. The company has also developed cloud-based management tools for employers and insurers to effectively manage their healthcare plans. Additionally, NexgenRx provides a modern and simple eClaims system for healthcare service providers, as well as a variety of consulting services aimed at optimizing healthcare plans. In conclusion, NexgenRx Inc. is an innovative company specializing in providing customer-oriented healthcare solutions. The company serves a diverse customer base and offers various products and services, including cloud-based management tools, eClaims systems, and consulting services. Overall, NexgenRx plays a significant role in the healthcare industry by improving the efficiency and quality of insurance processes. NexgenRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NexgenRx stock

EBITDA per Employee of NexgenRx is 111,642.15 CAD in 2025.

EBITDA per Employee of NexgenRx changed from 123,190.30 CAD to 111,642.15 CAD, representing a -9.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee NexgenRx since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's NexgenRx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — NexgenRx

All Key Metrics — NexgenRx